PARMAR KUSH 4
4 · Entrada Therapeutics, Inc. · Filed Jul 11, 2025
Insider Transaction Report
Form 4
PARMAR KUSH
Director10% Owner
Transactions
- Sale
Common Stock
2025-07-09$7.50/sh−20,065$150,528→ 3,163,066 total(indirect: By 5AM Ventures V, L.P.) - Sale
Common Stock
2025-07-09$7.50/sh−6,935$52,026→ 1,093,313 total(indirect: By 5AM Opportunities I, L.P.)
Footnotes (2)
- [F1]Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
- [F2]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.